Dallas, TX: ReportsandReports announce it will carry Abbott Laboratories Market Share Analysis Market Research Report in its Store. Browse complete Abbott Laboratories Market Share Analysis Report This report is an essential source for data, analysis and strategic insight into the medical equipment business of Abbott Laboratories. The report provides key information relating to Abbott Laboratories medical equipment revenue, market share by sector and country, financial and SWOT analysis of the company. The report examines the medical equipment business structure and operations, history and products, and provides an analysis of its key medical equipment revenue lines. It inspects the company’s strategic strengths and weaknesses. Scope Reasons to buy 1 Table of Contents 1.1 List of Tables 9 1.2 List of Figures 11 2 Introduction 2.1 What Is This Report About? 14 3 Definitions of Markets/Categories Covered 3.1 In Vitro Diagnostics 15 3.1.1 Clinical Chemistry 15 3.1.2 Genetic Testing 15 3.1.3 Haematology 15 3.1.4 Histology and Cytology 15 3.1.5 Immuno Chemistry 15 3.1.6 Infectious Immunology 15 3.2 Cardiovascular Devices 16 3.2.1 Interventional Cardiology 16 3.2.2 Peripheral Vascular Devices 16 3.3 Diabetes Care Devices 16 3.3.1 Glucose Monitoring 16 4 Company Snapshot 4.1 Key Information 17 4.2 Company Overview 17 4.3 Financial Performance 17 4.4 SWOT Snapshot 17 5 Business Description 5.1 Business Overview 18 5.2 Diagnostics 18 5.2.1 Overview 18 5.2.2 Financials 18 5.2.3 Market View 18 5.2.4 Key Strategies 18 5.3 Nutritionals 19 5.3.1 Overview 19 5.3.2 Financials 19 5.3.3 Market View 19 5.3.4 Key Strategies 19 5.4 Pharmaceuticals 19 5.4.1 Overview 19 5.4.2 Financials 19 5.4.3 Market View 19 5.4.4 Key Strategies 20 5.5 Vascular 20 5.5.1 Overview 20 5.5.2 Financials 20 5.5.3 Market View 20 5.5.4 Key Strategies 20 5.6 Major Products and Services 21 5.6.1 Overview 21 6 History 7 SWOT Analysis 7.1 Overview 27 7.2 Abbott Laboratories Strengths 28 7.2.1 Efficient Use of Resources 28 7.2.2 Strong Financial Performance 28 7.2.3 Diversified Geographic Presence 28 7.2.4 Diverse Product Portfolio 28 7.3 Abbott Laboratories Weaknesses 29 7.3.1 Product Recalls 29 7.3.2 Limited Liquidity Position 29 7.3.3 Legal Proceedings 29 7.4 Abbott Laboratories Opportunities 30 7.4.1 Expansion 30 7.4.2 Growing Aged Population 30 7.4.3 Market Growth in Emerging Economies 30 7.4.4 Growing Blood Glucose Monitoring Market 30 7.4.5 Strategic Acquisitions 31 7.5 Abbott Laboratories Threats 31 7.5.1 Increased Pricing Control 31 7.5.2 Tightening of the FDA’s Regulatory Oversight 31 7.5.3 Competitive Landscape 31 7.5.4 Technological Changes 32 8 Competitors 9 Competitive Landscape 9.1 In Vitro Diagnostics, Global, Company Share (%), 2009 34 9.2 Cardiovascular Devices, Global, Company Share (%), 2009 36 9.3 Diabetes Care Devices, Global, Company Share (%), 2009 38 10 Abbott Laboratories Medical Equipment Market Share Analysis 10.1 Abbott Laboratories, Global, Market Share (2009) 40 10.2 Abbott Laboratories, Asia-Pacific, Market Share (2009) 42 10.2.1 Abbott Laboratories, Australia, Market Share (2009) 44 10.2.2 Abbott Laboratories, China, Market Share (2009) 46 10.2.3 Abbott Laboratories, India, Market Share (2009) 48 10.2.4 Abbott Laboratories, Japan, Market Share (2009) 50 10.2.5 Abbott Laboratories, Other Asia-Pacific, Market Share (2009) 52 10.3 Abbott Laboratories, Europe, Market Share (2009) 54 10.3.1 Abbott Laboratories, France, Market Share (2009) 56 10.3.2 Abbott Laboratories, Germany, Market Share (2009) 58 10.3.3 Abbott Laboratories, Italy, Market Share (2009) 60 10.3.4 Abbott Laboratories, Spain, Market Share (2009) 62 10.3.5 Abbott Laboratories, United Kingdom, Market Share (2009) 64 10.3.6 Abbott Laboratories, Other Europe, Market Share (2009) 66 10.4 Abbott Laboratories, Middle East and Africa, Market Share (2009) 68 10.5 Abbott Laboratories, North America, Market Share (2009) 70 10.5.1 Abbott Laboratories, Canada, Market Share (2009) 72 10.5.2 Abbott Laboratories, United States, Market Share (2009) 74 10.6 Abbott Laboratories, South and Central America, Market Share (2009) 76 10.6.1 Abbott Laboratories, Brazil, Market Share (2009) 78 10.6.2 Abbott Laboratories, Other South and Central America, Market Share (2009) 80 11 Abbott Laboratories Medical Equipment Market Share Analysis by Category 11.1 Abbott Laboratories, Global, Category Revenue Share (2009) 82 11.2 Abbott Laboratories, Asia-Pacific, Category Revenue Share (2009) 85 11.2.1 Abbott Laboratories, Australia, Category Revenue Share (2009) 88 11.2.2 Abbott Laboratories, China, Category Revenue Share (2009) 91 11.2.3 Abbott Laboratories, India, Category Revenue Share (2009) 94 11.2.4 Abbott Laboratories, Japan, Category Revenue Share (2009) 97 11.2.5 Abbott Laboratories, Other Asia-Pacific, Category Revenue Share (2009) 100 11.3 Abbott Laboratories, Europe, Category Revenue Share (2009) 103 11.3.1 Abbott Laboratories, France, Category Revenue Share (2009) 106 11.3.2 Abbott Laboratories, Germany, Category Revenue Share (2009) 109 11.3.3 Abbott Laboratories, Italy, Category Revenue Share (2009) 112 11.3.4 Abbott Laboratories, Spain, Category Revenue Share (2009) 115 11.3.5 Abbott Laboratories, United Kingdom, Category Revenue Share (2009) 118 11.3.6 Abbott Laboratories, Other Europe, Category Revenue Share (2009) 121 11.4 Abbott Laboratories, Middle East and Africa, Category Revenue Share (2009) 124 11.5 Abbott Laboratories, North America, Category Revenue Share (2009) 127 11.5.1 Abbott Laboratories, Canada, Category Revenue Share (2009) 130 11.5.2 Abbott Laboratories, United States, Category Revenue Share (2009) 133 11.6 Abbott Laboratories, South and Central America, Category Revenue Share (2009) 136 11.6.1 Abbott Laboratories, Brazil, Category Revenue Share (2009) 139 11.6.2 Abbott Laboratories, Other South and Central America, Category Revenue Share (2009) 142 12 Key Employees 13 Key Employee Biographies 14 Company Statement 15 Locations And Subsidiaries 15.1 Head Office 151 15.2 Other Locations & Subsidiaries 151 16 Financial Deals Landscape 16.1 Abbott Laboratories, Deals Volume Summary, 2005 to YTD 2010 154 17 Abbott Laboratories Detailed Deal Summary 17.1 Asset Purchase 158 17.1.1 Boston Scientific To Sell Pain Management Unit 158 17.2 Partnerships 160 17.2.1 Fujirebio Diagnostics Signs Licensing Agreement with Abbott Laboratories 160 17.2.2 Rubicon Genomics Enters Into An Agreement With Abbott Laboratories 161 17.3 Acquisition 162 17.3.1 Abbott Laboratories Acquires Evalve 162 17.3.2 Abbott Laboratories Completes Acquisition of Visiogen 164 18 Recent Developments 18.1 Strategy and Business Planning 166 18.1.1 May 05, 2010: Abbott Opens Asia-Pacific Nutrition Research And Development Center In Singapore 166 18.1.2 Nov 17, 2009: Abbott Signs Agreement With BG Medicine For Development Of Heart Failure Test 166 18.1.3 Nov 15, 2009: Abbott Enters Into Agreement With PanGenetics 167 18.1.4 Nov 12, 2009: Abbott To Acquire PanGenetics BV’s NGF Inhibitor To Treat Chronic Pain 167 18.1.5 Nov 12, 2009: Abbott To Acquire PanGenetics’ Investigational Antibody To Treat Chronic Pain 167 18.1.6 Aug 27, 2009: Abbott Enters Into Agreement With Pfizer 168 18.1.7 Aug 18, 2009: Abbott Signs Partnership Agreement With Velcera For Pain Drug 168 18.2 Financial Announcements 169 18.2.1 Apr 21, 2010: Abbott Reports Net Earnings Of $1 Billion In Q1 2010 169 18.2.2 Jan 27, 2010: Abbott Reports Net Earnings Of $5.7 Million In 2009 169 18.2.3 Oct 14, 2009: Abbott Reports Net Earnings Of $1.5 Billion In Q3 2009 171 18.2.4 Oct 14, 2009: Abbott Q3 2009 Net Income Increases By 36.5% 172 18.3 Research and Development 173 18.3.1 Oct 23, 2009: Abbott Launches New R&D Facility At University of Illinois 173 18.4 Corporate Communications 173 18.4.1 Dec 03, 2009: Abbott Lays off about 80 Jobs at Its Temecula Factory, California 173 18.5 Legal and Regulatory 173 18.5.1 May 05, 2010: Watson Confirms SIMCOR Patent Challenge 173 18.5.2 Nov 11, 2009: Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 174 18.5.3 Aug 26, 2009: New Jersey Doctor Files Patent Lawsuit Against Abbott Over Heart Stents 174 18.6 Government and Public Interest 175 18.6.1 Apr 15, 2010: Abbott Begins Biopreparedness Evaluation Program with State Public Health Labs 175 18.6.2 Nov 17, 2009: FDA Warns Abbott on Manufacturing Practices At Des Plaines Facility 176 18.6.3 Nov 16, 2009: Federal Sales Tax on Medical Devices Would Cost Millions 176 18.6.4 Oct 20, 2009: FDA Grants 510(k) Clearance To Abbott For Cyclic-Citrulinated Peptide 176 18.6.5 Sep 14, 2009: SFDA Approves Abbott’s XIENCE V Drug Eluting Stent 177 18.6.6 Sep 14, 2009: Abbott Obtains European Approval For Kaletra Tablet 177 18.6.7 Sep 14, 2009: Abbott Obtains European Approval For Once-daily Dosing of Kaletra Tablet 177 18.7 Product News 178 18.7.1 Jun 03, 2010: Abbott Receives FDA Clearance For ARCHITECT HE4 Assay 178 18.7.2 May 19, 2010: Abbott Receives BLA Approval From FDA For ABBOTT PRISM Chagas Test 178 18.7.3 Apr 30, 2010: Abbott Receives FDA Approval For Abbott Prism Chagas 179 18.7.4 Apr 30, 2010: FDA Announces Class II Recall Of Abbott’s Freestyle Navigator Continuous Glucose Monitor System 179 18.7.5 Feb 08, 2010: Abbott Files FDA 510(K) Application For ARCHITECT HE4 Assay 179 18.7.6 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 180 18.7.7 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 180 18.7.8 Sep 15, 2009: Abbott Gains Top Honor In Wall Street Journal Technology Innovation Awards for Its PLEX-ID 180 18.8 Product Approvals 181 18.8.1 Jun 03, 2010: Abbott Receives FDA Clearance For ARCHITECT HE4 Assay 181 18.8.2 May 19, 2010: Abbott Receives BLA Approval From FDA For ABBOTT PRISM Chagas Test 182 18.8.3 Apr 30, 2010: Abbott Receives FDA Approval For Abbott Prism Chagas 182 18.8.4 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 182 18.8.5 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 184 18.9 Other Significant Developments 184 18.9.1 Jan 13, 2010: Abbott to Provide $1 Million In Funding, Products To Help Address Health Needs In Haiti 184 18.9.2 Nov 02, 2009: Abbott Saves 1 Billion Gallons of Water Annually 185 18.9.3 Oct 14, 2009: Abbott Reports 36.5% Surge in Q3 Earnings 186 18.9.4 Sep 16, 2009: Abbott Expands Use Of Sustainable Packaging As Part Of Global Environmental Efforts 186 19 Appendix 19.1 Research Methodology 189 19.2 Secondary Research 190 19.3 Primary Research 190 19.4 Models 191 19.5 Forecasts 191 19.6 Expert Panels 191 19.7 GlobalData Consulting 191 19.8 Currency Conversion 192 19.9 Contact Us 193 19.10 Disclaimer 193 Browse complete Abbott Laboratories Market Share Analysis Report Browse all Medical Devices Market Research Reports Browse all GlobalData Market Research Reports Browse all Latest Report Related Reports: Abbott Medical Optics, Inc. Market Share Analysis Abbott Laboratories – SWOT Analysis Abbott Laboratories: PharmaVitae Profile About Us: Contact:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
Posted by
Unknown
on